Development Level

Tbio 15 | 10,625
Tclin 4 | 602
Tchem 3 | 1,890

IMPC Term

decreased circulating choleste... 2 | 85
increased circulating alkaline... 2 | 119
increased leukocyte cell numbe... 2 | 37
abnormal behavior 1 | 226
abnormal bone structure 1 | 131
abnormal eye anterior chamber ... 1 | 3
abnormal femur morphology 1 | 14
abnormal vibrissa morphology 1 | 17
decreased CD4-positive, alpha ... 1 | 19
decreased NK T cell number 1 | 28
decreased T cell number 1 | 31
decreased alpha-beta T cell nu... 1 | 12
decreased body length 1 | 108
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 77
decreased circulating LDL chol... 1 | 37
decreased circulating amylase ... 1 | 24
decreased circulating fructosa... 1 | 31
decreased circulating glucose ... 1 | 121
decreased effector memory CD4-... 1 | 6
decreased effector memory CD8-... 1 | 24
decreased gamma-delta T cell n... 1 | 18
decreased lean body mass 1 | 195
female infertility 1 | 34
increased B cell number 1 | 23
increased CD8-positive, alpha-... 1 | 11
increased KLRG1-positive NK ce... 1 | 9
increased Ly6C high monocyte n... 1 | 12
increased Ly6C low monocyte nu... 1 | 8
increased NK cell number 1 | 19
increased circulating bilirubi... 1 | 16
increased circulating iron lev... 1 | 25
increased eosinophil cell numb... 1 | 9
increased lymphocyte cell numb... 1 | 9
increased mature B cell number 1 | 12
increased mean corpuscular hem... 1 | 93
increased mean corpuscular vol... 1 | 91
increased monocyte cell number 1 | 27
increased or absent threshold ... 1 | 128
male infertility 1 | 62
preweaning lethality, complete... 1 | 633
thrombocytopenia 1 | 46

Disease

psoriasis 14 | 6,685
osteosarcoma 11 | 7,933
ovarian cancer 10 | 8,484
invasive ductal carcinoma 9 | 2,950
Breast cancer 8 | 3,094
Obesity 8 | 616
diabetes mellitus 8 | 1,663
lung cancer 8 | 4,466
Cancer 7 | 2,346
Carcinoma 7 | 2,147
Kidney disease 7 | 396
cystic fibrosis 7 | 1,665
ulcerative colitis 7 | 2,087
breast carcinoma 6 | 1,614
ductal carcinoma in situ 6 | 1,745
lung adenocarcinoma 6 | 2,713
lung carcinoma 6 | 2,844
malignant mesothelioma 6 | 3,162
Atherosclerosis 5 | 275
Heart disease 5 | 279
cutaneous lupus erythematosus 5 | 1,056
ependymoma 5 | 2,514
glioblastoma 5 | 5,572
intraductal papillary-mucinous adenoma (IPMA) 5 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,289
non-small cell lung cancer 5 | 2,798
Cerebrovascular disease 4 | 231
Coronary artery disease 4 | 240
Duchenne muscular dystrophy 4 | 602
Hypertension 4 | 287
Osteoporosis 4 | 257
Rheumatoid Arthritis 4 | 1,160
Thrombocytopenia 4 | 105
adrenocortical carcinoma 4 | 1,427
interstitial cystitis 4 | 2,299
interstitial lung disease 4 | 291
pediatric high grade glioma 4 | 2,712
pilocytic astrocytoma 4 | 3,086
Anemia 3 | 252
Atopic dermatitis 3 | 944
Down syndrome 3 | 548
Multiple myeloma 3 | 1,327
Myopathy 3 | 128
Neurodegenerative disease 3 | 383
Toxic encephalopathy 3 | 131
active ulcerative colitis 3 | 477
astrocytic glioma 3 | 2,241
atypical teratoid / rhabdoid tumor 3 | 4,369
hepatocellular carcinoma 3 | 532
medulloblastoma, large-cell 3 | 6,234
oligodendroglioma 3 | 2,849
pancreatic cancer 3 | 2,300
sarcoidosis 3 | 358
subependymal giant cell astrocytoma 3 | 2,287
Arsenic Poisoning 2 | 59
Arthritis 2 | 248
Bipolar Disorder 2 | 266
Brain Ischemia 2 | 87
Crohn Disease 2 | 97
Dementia 2 | 129
Epilepsy 2 | 346
Exanthem 2 | 39
Eye disease 2 | 55
Inflammation 2 | 109
Inflammatory bowel disease 2 | 142
Keratitis 2 | 42
Liver carcinoma 2 | 217
Liver disease 2 | 219
Major Depressive Disorder 2 | 106
Malaria 2 | 140
Migraine 2 | 79
Neuropathy 2 | 210
Parkinson's disease 2 | 364
Peripheral vascular disease 2 | 90
Peritonitis 2 | 37
Pick disease 2 | 1,893
Polycystic Ovary Syndrome 2 | 332
Urticaria 2 | 53
Vascular disease 2 | 281
active Crohn's disease 2 | 918
adult high grade glioma 2 | 2,148
atypical teratoid/rhabdoid tumor 2 | 1,095
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
chronic rhinosinusitis 2 | 512
colon cancer 2 | 1,475
dermatomyositis 2 | 933
esophageal adenocarcinoma 2 | 737
fibroadenoma 2 | 557
medulloblastoma 2 | 1,524
nephrosclerosis 2 | 329
non-small cell lung carcinoma 2 | 413
pancreatic carcinoma 2 | 567
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pituitary cancer 2 | 1,972
posterior fossa group A ependymoma 2 | 1,511
sonic hedgehog group medulloblastoma 2 | 1,482
systemic lupus erythematosus 2 | 156
tuberculosis 2 | 1,557
tuberculosis and treatment for 6 months 2 | 686

Tissue

Blood and immune system 22 | 17,995
Cardiovascular System 22 | 17,958
Digestive Tract 22 | 18,473
Endocrine System 22 | 18,512
Female tissues 22 | 18,647
Liver and Pancreas 22 | 18,136
Male tissues 22 | 17,969
Nervous System 22 | 18,561
Respiratory system 22 | 17,484
Skin and soft tissues 22 | 18,115
Urinary Tract 22 | 18,444

Target Family

Non-IDG 13 | 11,971
Enzyme 6 | 4,146
GPCR 1 | 406
Kinase 1 | 634
Transcription Factor 1 | 1,400

Grant Application

5P41RR001777-19 22 | 22
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
C-reactive protein CRP Tbio Non-IDG -4.51399 33883.5 1160
Plasma kallikrein KLKB1 Tclin Enzyme -2.88472 708.0 231
Cysteine-rich protein 2 CRIP2 Tbio Non-IDG -0.95386 10.4 115
Period circadian protein homolog 1 PER1 Tbio Non-IDG -1.79100 61.2 150
InaD-like protein PATJ Tbio Non-IDG -1.88739 77.1 91
Cytochrome c CYCS Tbio Non-IDG -3.73952 4771.4 630
Prolactin-inducible protein PIP Tbio Non-IDG -2.50637 349.1 314
Maltase-glucoamylase, intestinal MGAM Tclin Enzyme -4.44117 27956.4 30
NACHT, LRR and PYD domains-containing protein 3 NLRP3 Tchem Non-IDG -3.18465 1655.7 459
Four and a half LIM domains protein 1 FHL1 Tbio Non-IDG -2.41345 273.2 273